US
U.S. Stem Cell, Inc.
USRM · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $64.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.78x
PEG N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 70.11%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 3,483.21%
Op. margin 2,096.90%
FCF margin 371.55%
Quality
79 /100
Excellent ROA 4,200.45%
Asset turnover 1.21x
ROIC 29.95%
Debt
50 /100
Moderate Int. coverage -3.14x
Net debt/EBITDA -4.12x
Current ratio 0.00x
Stability
46 /100
Moderate Rev. volatility 31.72%
EPS volatility 22.33%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre USRM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Tomas
Employees
11
Headquarters
Sunrise